Lipidated peptides are mainstays of type II diabetes treatment and provided some stabilization as indicated in this study.[25] While mimicking the VEGFR1 binding site could activate the neuroprotective functions of VEGF‐B[15] the peptides described here could be specific blockers of VEGF‐B function. Here, VEGFB is linked to type 2 diabetes mellitus.